ARCHIVES

Oral Complications Reduced By Pretherapy NIH Conference Finds

This article is from The Cancer Letter archive.

Vol. 15 No. 17 | April 28, 1989

Download PDF Visit The Full Archive

Related Articles

NAS Committee Urges Greater Rewards For Interdisciplinary Research.

January 21, 2005

Texas Oncology Designated Aranesp As Preferred Treatment

December 13, 2002

Clinical Trials Working Group Offers 21 Recommendations to improve efficiency of trials.

February 25, 2005

Wyngaarden Helps Make Case For Facilities Funding, Reveals Plan For New NIH Building

April 15, 1988

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

Clinical Research Program Announcement

February 13, 1981